Berlin Heals Holding AG Successfully Completes Financing Round for Ongoing CE-Study

Marko Bagaric, Chief Executive Officer, Berlin Heals Holding AG comments: Marko Bagaric, Chief Executive Officer, Berlin Heals Holding AG comments: "We have initiated the financing round with the objective to complete the CE-certification study swiftly and successfully. I am particularly delighted that we could win the Swiss company Fumedica, a special provider in heart surgery and invasive cardiology, as a new investor. Fumedica, in fact, could play an important role in the initial...

Marko Bagaric, Chief Executive Officer, Berlin Heals Holding AG comments:

"We have initiated the financing round with the objective to complete the CE-certification study swiftly and successfully. I am particularly delighted that we could win the Swiss company Fumedica, a special provider in heart surgery and invasive cardiology, as a new investor. Fumedica, in fact, could play an important role in the initial distribution of the product in the DACH region. We are convinced that Berlin Heals Holding AG's groundbreaking technology will have a significant impact, for heart insufficiency which remains widespread and a leading cause of death worldwide."

Berlin Heals Holding AG is a Swiss joint-stock company founded in 2014 by renowned heart specialists and engineers. The start-up has developed a revolutionary implantable device called "C-MIC" (Cardiac Microcurrent), which - by way of a constant electrical microcurrent and the ensuing electrical field - results in a sustainable and swift improvement of the texture of heart tissue of heart failure patients. To date over 35 C-MIC devices have been implanted with very good results.

Logo - https://mma.prnewswire.com/media/1843666/Berlin_Heals_Logo.jpg

Contact person:
Marko Bagaric
info@berlinheals.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/berlin-heals-holding-ag-successfully-completes-financing-round-for-ongoing-ce-study-301865825.html